The Food and Drug Administration on Tuesday cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes, giving the tobacco giant a major regulatory win as the Trump administration loosens restrictions on nicotine products.
The decision, first reported by Axios, allows 20 Zyn products to carry a modified-risk claim saying that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Zyn pouches contain nicotine but not tobacco. They are placed between a user’s gum and lip and have surged in popularity among conservatives, tech workers and others who promote them as a cleaner alternative to cigarettes and chewing tobacco or a productivity aid.
It passed the AMES test.
Vaping can potentially cause minute amounts of harmful chemicals if you greatly misuse the device, but the studies that found that had methodologies designed to produce harmful chemicals (like firing the coil for 90s at double the normal voltage)
And it’s always left out that any harmful chemicals are orders of magnitude lower than in tobacco.